New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages

Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb...

Descripción completa

Detalles Bibliográficos
Autores principales: Haake, Kathrin, Lachmann, Nico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915800/
https://www.ncbi.nlm.nih.gov/pubmed/31951563
http://dx.doi.org/10.1016/j.stemcr.2019.11.006
_version_ 1783480100495294464
author Haake, Kathrin
Lachmann, Nico
author_facet Haake, Kathrin
Lachmann, Nico
author_sort Haake, Kathrin
collection PubMed
description Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb using pluripotent stem cell-derived macrophages.
format Online
Article
Text
id pubmed-6915800
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69158002019-12-23 New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages Haake, Kathrin Lachmann, Nico Stem Cell Reports Preview Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb using pluripotent stem cell-derived macrophages. Elsevier 2019-12-10 /pmc/articles/PMC6915800/ /pubmed/31951563 http://dx.doi.org/10.1016/j.stemcr.2019.11.006 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Preview
Haake, Kathrin
Lachmann, Nico
New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_full New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_fullStr New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_full_unstemmed New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_short New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_sort new drugs for an old foe: mycobacterium tuberculosis meets psc-derived macrophages
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915800/
https://www.ncbi.nlm.nih.gov/pubmed/31951563
http://dx.doi.org/10.1016/j.stemcr.2019.11.006
work_keys_str_mv AT haakekathrin newdrugsforanoldfoemycobacteriumtuberculosismeetspscderivedmacrophages
AT lachmannnico newdrugsforanoldfoemycobacteriumtuberculosismeetspscderivedmacrophages

Ejemplares similares